Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesPharmacy & Specialty DrugsMedImpact Kentucky Medicaid Prior Auth | OpenPayer
    Ask Trek AI about this page
    CurrentMedImpactPolicy N/A

    Kentucky Medicaid Prior Authorization Criteria

    Customize your policy alerts

    Sign up for all medimpact policy alerts

    Know when medimpact releases new policies or updates existing guidance.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Prior authorization criteria for pharmacy and specialty drugs covered under Kentucky Medicaid.

    Policy Summary
    PayerMedImpact
    PolicyKentucky Medicaid Prior Authorization Criteria
    Policy CodePolicy N/A
    Change TypeNo material change
    Effective DateSeptember 1, 2026
    Next Review DateN/A
    Key ActionBefore approval of a non-preferred agent, document a qualifying trial, failure, allergy, contraindication, or intolerance involving 2 preferred agents in any subclass.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    Kentucky MedicaidCovered program
    Sep 2026Version
    1 yearStandard approval duration
    ≥30 daysRequired trial duration
    2Preferred agents required

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    Preferred and Non-Preferred Agent Criteria

    Preferred with PA (PDP) Criteria

    Not applicable. All preferred agents are preferred without prior authorization.

    Preferred with PA (PDP) criteria do not apply because all preferred agents are preferred without prior authorization.

    Non-preferred (NPD) Criteria

    Approval of non-preferred agents requires the following, unless otherwise specified:

    ALL of the following

    • The member has completed a trial of at least 30 days with 2 preferred agents in any sub-class.
    • At least ONE of the following occurred with the preferred agents

      • Failure
      • Allergy
      • Contraindication, including potential drug-drug interactions with other medications
      • Intolerance

    Authorization and Documentation Requirements

    Note

    Preferred Agents Do Not Require Prior Authorization

    Preferred agents are available without prior authorization. No preferred-agent prior authorization criteria apply.

    Prior Authorization

    Non-Preferred Agent Authorization

    Authorization is required for a non-preferred agent. Approval requires a documented qualifying exception involving two preferred agents in any sub-class, unless otherwise specified.

    Step Therapy

    Trial and Failure of Two Preferred Agents

    Before a non-preferred agent can be approved, the patient must have completed a trial of at least 30 days and failed two preferred agents in any sub-class, unless otherwise specified.

    Non-Preferred Initial Therapy

    Non-preferred Initial Therapy

    Approval of a non-preferred agent requires one qualifying exception, unless otherwise specified.

    ONE of

    • The member has completed at least a 30-day trial and failed 2 preferred agents in any subclass.At least 30 days; 2 preferred agents
    • The member has an allergy to 2 preferred agents.2 preferred agents
    • The member has a contraindication, including potential drug-drug interactions with other medications, to 2 preferred agents.2 preferred agents

    Preferred-Agent Step Therapy

    StepRequirementQualifying documentation
    1Try 2 preferred agents in any subclass before approval of a non-preferred agent, unless otherwise specified.Document an at least 30-day trial and failure, allergy, contraindication (including potential drug-drug interactions with other medications), or intolerance of 2 preferred agents.
    Policy Summary
    PayerMedImpact
    PolicyKentucky Medicaid Prior Authorization Criteria
    Policy CodePolicy N/A
    Change TypeNo material change
    Effective DateSeptember 1, 2026
    Next Review DateN/A
    Key ActionBefore approval of a non-preferred agent, document a qualifying trial, failure, allergy, contraindication, or intolerance involving 2 preferred agents in any subclass.
    SourceLink
    On This Page
    Preferred and Non-Preferred Agent CriteriaAuthorization and Documentation RequirementsPolicy BackgroundNon-Preferred Initial TherapyPreferred-Agent Step Therapy
    • Minimum trial duration: 30 days
    Documentation Required

    Document Preferred-Agent History

    Document the applicable history for both preferred agents: a trial of at least 30 days with failure, allergy, contraindication (including potential drug-drug interactions with other medications), or intolerance.

    • The documented exception may be failure, allergy, contraindication, potential drug-drug interaction, or intolerance.
    • The preferred-agent history must involve two agents in any sub-class, unless otherwise specified.
    Denial Risk

    Criteria Not Met May Result in Denial

    A non-preferred agent may be denied when the required trial, failure, or other qualifying exception for two preferred agents is not documented or does not meet the applicable criteria.

    The member has intolerance to 2 preferred agents.2 preferred agents